Logo
x

Search category

Subscribe Now

OASIS-2

Eli Lilly Reports Results of Mirikizumab in P-III OASIS-2 Study to Treat Moderate to Severe Plaque Psoriasis

Eli Lilly Reports Results of Mirikizumab in P-III OASIS-2 Study to Treat Moderate to Severe Plaque Psoriasis

  • July 17, 2020
Paratek Reports Results of Nuzyra (omadacycline) in P-III OASIS-2 Study for Skin Infections

Paratek Reports Results of Nuzyra (omadacycline) in P-III OASIS-2 Study for Skin Infections

  • August 30, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.